Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.47
-0.02 (-0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
9.37
-0.10 (-1.06%)
Pre-market: Apr 29, 2026, 4:20 AM EDT
Haleon Market Cap
Haleon has a market cap or net worth of $42.16 billion as of April 28, 2026. Its market cap has decreased by -6.51% in one year.
Market Cap
42.16B
Enterprise Value
52.08B
1-Year Change
-6.51%
Ranking
Category
Stock Price
$9.47
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $42.16B, an increase of 23.48%. That is a compound annual growth rate of 5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 42.16B | -6.15% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 52.36B |
| Zoetis | 49.36B |
| Teva Pharmaceutical Industries | 36.35B |
| United Therapeutics | 24.84B |
| Viatris | 17.15B |
| Regencell Bioscience Holdings | 14.20B |
| Neurocrine Biosciences | 12.82B |
| Dr. Reddy's Laboratories | 11.99B |